Evidence map›Paper›PMID 30077007›Full record

ArticleBiochimica et biophysica acta. Molecular and cell biology of lipids2018

Inhibition of pannexin-1 channel activity by adiponectin in podocytes: Role of acid ceramidase activation.

Guangbi Li, Qinghua Zhang, Jinni Hong, Joseph K Ritter, Pin-Lan Li

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta. Molecular and cell biology of lipids, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Pannexin channels in the kidney.American journal of physiology. Renal physiology · 2025
    Review
  4. Sphingolipid signaling in kidney diseases.American journal of physiology. Renal physiology · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Adiponectin in Chronic Kidney Disease.International journal of molecular sciences · 2020
    Review
  13. Review
  14. Review
  15. Podocyte Lysosome Dysfunction in Chronic Glomerular Diseases.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Guangbi LiDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, School of Medicine, Richmond, VA 23298, United States of America.
Qinghua ZhangDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, School of Medicine, Richmond, VA 23298, United States of America.
Jinni HongDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, School of Medicine, Richmond, VA 23298, United States of America.
Joseph K RitterDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, School of Medicine, Richmond, VA 23298, United States of America.
Pin-Lan LiDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, School of Medicine, Richmond, VA 23298, United States of America. Electronic address: pin-lan.li@vcuhealth.org.
Virginia Commonwealth University · US

Funding

Hypertension and glomerular injury in hyperhomocysteinemia - role of inflammatory exosomesR01DK054927 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI LI, PINLAN · 1998 to 2023
$6.7M
Lysosome dysfunction in podocytopathy and associated hypertensionR01DK120491 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI LI, PINLAN · 2018 to 2022
$2.4M
Renomedullary metabolism of anandamide and blood pressure regulationR01DK102539 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI LI, PINLAN, RITTER, JOSEPH K. · 2016 to 2019
$1.4M
Renomedullary metabolism of anandamide and blood pressure regulationR56DK102539 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI LI, PINLAN, RITTER, JOSEPH K. · 2014 to 2014
$92k
NIDDK NIH HHS R01 DK054927NIDDK NIH HHS R01 DK102539NIDDK NIH HHS R01 DK120491NIDDK NIH HHS R56 DK102539
6 · The paper itself

Abstract

The pannexin-1 (Panx1) channel has been reported to mediate the release of ATP that is involved in local tissue inflammation, obesity, and many chronic degenerative diseases. It remains unknown whether Panx1 is present in podocytes and whether this channel in podocytes mediates ATP release leading to glomerular inflammation or fibrosis. To answer these questions, we first characterized the expression of Panx channels in podocytes. Among the three known pannexins, Panx1 was the most enriched in podocytes, either cultured or native in mouse glomeruli. Using a Port-a-Patch planar patch-clamp system, we recorded a large voltage-gated outward current through podocyte membrane under the Cs

Indexed as

Acid CeramidaseAdenosine TriphosphateAdiponectinAnimalsAspartic AcidCells, CulturedConnexinsEnzyme ActivationGluconatesLysophospholipidsMiceNerve Tissue ProteinsPodocytesPotassium ChannelsSphingosineAcid CeramidaseAdenosine TriphosphateAdiponectinAdipoq protein, mouseAsah1 protein, mouseAspartic AcidConnexinsGluconatesgluconic acidLysophospholipidsNerve Tissue ProteinsPanx1 protein, mousePotassium ChannelsSphingosinesphingosine 1-phosphateAcid ceramidaseAdiponectinATP releaseInflammasomePannexin-1 channelPodocytes

Identifiers

PMID30077007
PMCPMC6180945
OpenAlexW2887493218

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.